| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/15/2000 | DE19856432A1 Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen Nanoparticulate core-shell systems and their use in pharmaceutical and cosmetic preparations |
| 06/15/2000 | CA2732620A1 Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 06/15/2000 | CA2651609A1 Crystalline form of 40-o- (2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 06/15/2000 | CA2354868A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 06/15/2000 | CA2354766A1 Prodrug compounds and process for preparation thereof |
| 06/15/2000 | CA2354233A1 Self-emulsifying compositions for drugs poorly soluble in water |
| 06/15/2000 | CA2354022A1 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase |
| 06/15/2000 | CA2354021A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative |
| 06/15/2000 | CA2353942A1 Method for preparation of disodium pamidronate |
| 06/15/2000 | CA2353832A1 Conjugates of lipids and antimicrobial or antineoplastic drugs |
| 06/15/2000 | CA2353809A1 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations |
| 06/15/2000 | CA2353620A1 Methods and formulations for reducing circulating antibodies |
| 06/15/2000 | CA2353552A1 Supramolecular complexes containing therapeutic agents |
| 06/15/2000 | CA2353522A1 Treatment of pompe's disease |
| 06/15/2000 | CA2352758A1 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same |
| 06/15/2000 | CA2352178A1 Phospholipid compositions |
| 06/15/2000 | CA2351890A1 Method and composition for preserving viruses |
| 06/15/2000 | CA2326842A1 Micronized eplerenone compositions |
| 06/14/2000 | EP1008355A1 Method for identifying or analyzing polymer linkage sites on macromolecules using amino acid report binding |
| 06/14/2000 | EP1008353A1 Saccharide-containing compositions |
| 06/14/2000 | EP1008350A1 Stabilised antithrombin III preparation |
| 06/14/2000 | EP1007729A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 06/14/2000 | EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 06/14/2000 | EP1007699A1 Peptide-enhanced transfections |
| 06/14/2000 | EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof |
| 06/14/2000 | EP1007680A2 Single and double chain antibodies to the egf receptor, derivatives thereof and their use |
| 06/14/2000 | EP1007634A1 Encapsulation of living tissue cells in a microsphere |
| 06/14/2000 | EP1007632A1 Isolation of bone and cartilage precursor cells |
| 06/14/2000 | EP1007569A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE $g(a)-GALACTOSYL EPITOPE |
| 06/14/2000 | EP1007561A2 Novel conjugates of opioids and endogenous carriers |
| 06/14/2000 | EP1007549A1 Compositions and methods for highly efficient transfection |
| 06/14/2000 | EP1007533A1 Bioconjugates and delivery of bioactive agents |
| 06/14/2000 | EP1007531A1 Branched dendrimeric structures |
| 06/14/2000 | EP1007506A2 Compositions and methods for reversibly increasing permeability of biomembranes |
| 06/14/2000 | EP1007107A2 Method for transporting a molecular substance in predetermined areas of eucaryotic cells |
| 06/14/2000 | EP1007101A2 Improvements in or relating to diagnostic/therapeutic agents |
| 06/14/2000 | EP1007097A1 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles |
| 06/14/2000 | EP1007096A1 Arginine silicate inositol complex and use thereof |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/14/2000 | EP1007094A1 Pharmaceutical compositions for freeze drying |
| 06/14/2000 | EP1007084A1 Immunogenic lhrh compositions and methods relating thereto |
| 06/14/2000 | EP1007083A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets |
| 06/14/2000 | EP1007080A1 Sustained peptide-release formulation |
| 06/14/2000 | EP1007077A1 Compounds and their combinations for the treatment of influenza infection |
| 06/14/2000 | EP1007060A2 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
| 06/14/2000 | EP1007054A1 Liquid alendronate formulations |
| 06/14/2000 | EP1007049A1 New pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
| 06/14/2000 | EP1007034A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 06/14/2000 | EP1007024A1 Delayed-release dosage forms of sertraline |
| 06/14/2000 | EP1007021A1 Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone |
| 06/14/2000 | EP1007015A1 In situ formation of polymeric material |
| 06/14/2000 | EP1007014A1 Transdermal, hormone-delivering therapeutic system |
| 06/14/2000 | EP1007013A1 Parenteral pimaricin as treatment of systemic infections |
| 06/14/2000 | EP1007012A1 Taste-masked microcapsule compositions and methods of manufacture |
| 06/14/2000 | EP1007011A1 Lock and key micelles |
| 06/14/2000 | EP1007010A2 Pharmaceutical composition comprising an azasteroid |
| 06/14/2000 | EP1007009A1 A pharmaceutical composition having two coating layers |
| 06/14/2000 | EP1007007A1 Ascorbic acid-based formulation with improved colour stability |
| 06/14/2000 | EP1007002A1 Lipid-containing compositions and uses thereof |
| 06/14/2000 | EP1007000A2 Stable particle in liquid formulations |
| 06/14/2000 | EP1006999A2 Use of submicron oil-in-water emulsions with dna vaccines |
| 06/14/2000 | EP1006998A1 Topical drug preparations |
| 06/14/2000 | EP1006986A1 Personal care compositions containing a copolymer having hydrophobic, carbon-based grafts |
| 06/14/2000 | EP1006969A1 Intranasal formulations for promoting sleep and method of using the same |
| 06/14/2000 | EP1006964A1 Intrauterine chemical necrosing method, composition, and apparatus |
| 06/14/2000 | EP1006935A1 High viscosity liquid controlled delivery system |
| 06/14/2000 | EP1006814A1 Edible, low calorie compostions of a carrier and an active ingredient and methods for preparation thereof |
| 06/14/2000 | EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer |
| 06/14/2000 | EP0904065A4 Microencapsulated fragrances and method for preparation |
| 06/14/2000 | EP0901463B1 Glycerolipidic compounds used for the transfer of an active substance into a target cell |
| 06/14/2000 | EP0830145B1 Formulations comprising leflunomide |
| 06/14/2000 | EP0746326A4 Oligomeric compounds having nitrogen-containing linkages |
| 06/14/2000 | CN1256700A Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles,and method for making and using the same |
| 06/14/2000 | CN1256633A Antibacterial composition for topical administration containing antibiotics |
| 06/14/2000 | CN1256631A Methods and composition for treating fungal infections in mannals |
| 06/14/2000 | CN1256628A Sustained-release compositions and method for preparing same |
| 06/14/2000 | CN1256626A Stable particle in liquid formulations |
| 06/14/2000 | CN1256625A Topical application of enzymes using peelable film |
| 06/14/2000 | CN1256148A Stable water solution of interferon |
| 06/14/2000 | CN1053383C Chewing pieces of Jingui Tonifying the kidney and prepn. thereof |
| 06/14/2000 | CN1053382C Chewing pieces for invigorating the spleen and replenishing qi and prepn. thereof |
| 06/14/2000 | CA2292241A1 Nanoemulsion comprised of fatty esters of sugar or fatty ethers of sugar and its cosmetic, dermatological and/or ophthalmologic applications |
| 06/13/2000 | US6075134 Glycoconjugates and methods |
| 06/13/2000 | US6075130 Calixarene containing upper rim and a lower rim, atleast one ionizable group attached to lower rim and a radionuclide ion from lantahnide elements bound to ionizable group |
| 06/13/2000 | US6075121 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
| 06/13/2000 | US6075107 Use of copolymers of N-vinylprrolidone in preparations of water-insoluble substances |
| 06/13/2000 | US6075032 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| 06/13/2000 | US6075010 Small molecular weight ligand-hexose containing clearing agents |
| 06/13/2000 | US6074848 Amino acid sequence; for antiproliferative and wound healing agents |
| 06/13/2000 | US6074840 Recombinant production of latent TGF-beta binding protein-3 (LTBP-3) |
| 06/13/2000 | US6074689 Colonic delivery of protein or peptide compositions |
| 06/13/2000 | US6074670 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 06/13/2000 | US6074666 Liposome compositions of porphyrin photosensitizers |
| 06/13/2000 | US6074661 Sterile bioerodible occular implant device with a retinoid for improved biocompatability |
| 06/13/2000 | US6074659 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/13/2000 | US6074653 Topical applicable |
| 06/13/2000 | US6074650 Membrane anchor/active compound conjugate, its preparation and its uses |
| 06/13/2000 | US6074644 Cytotoxic activity |
| 06/13/2000 | US6074643 Site-directed chemotherapy of metastases |
| 06/13/2000 | US6074636 Method of using cell surface receptor targeted molecules for the treatment of viral diseases |